Cibiem is a medical device company leveraging its proprietary, minimally invasive, catheter-based approach focused on Carotid Body Modulation (CBM) for the treatment of sympathetic nervous system-mediated diseases such as hypertension, heart failure, diabetes and renal failure. The company was co-founded by Mark Gelfand and Howard R. Levin, M.D., the proven team of innovators and entrepreneurs behind Coridea. The company is backed by top-tier venture investors Third Rock Ventures and SV Life Sciences.


CIBIEM LEADERSHIP/BIOS

Mark Gelfand

Chief Technical Officer

Mr. Gelfand has more than 20 years of experience developing medical devices in academic, start-up and corporate environments.

Howard R. Levin, M.D.

President

Dr. Levin is a cardiologist and an expert in the care of patients with heart failure, heart transplantation, mechanical cardiac assistance and intensive care.

Paul Alan Sobotka, M.D.,F.A.C.P., F.A.C.C.

Chief Medical Officer

Dr. Sobotka a cardiologist with clinical expertise in the care of patients with heart failure, volume overload and hypertension. He is currently on the strategic team for the Entrepreneur-in-Residence at the White House

CONTACT US

5150 El Camino Real, Suite E30, Los Altos, CA 94022
fax: 888.753.1663
info@cibiem.com

Cibiem Inc. 2014